AIBS joined the American Society for Microbiology and 64 other organizations representing public health, patients, and biomedical researchers in a letter requesting at least $7.15 billion for the National Institute of Allergy and Infectious Diseases (NIAID) and at least $51.303 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2027.
The requested level for NIAID is an 8.7% increase from FY 2026 levels, and is critical to ensuring the U.S. can respond to current and future disease threats.
“NIAID-funded research has fueled some of the biggest public health success stories in recent decades, such as the transformation of HIV/AIDS from a death sentence to a treatable, chronic condition thanks to the development of antiretroviral agents and the development of treatments, vaccines and diagnostics for RSV, tuberculosis, Ebola, type 1 Diabetes, malaria and more,” the letter reads. It encourages Congress to work together to ensure strong funding for the work at NIAID and NIH in FY 2027.
Stay current on the latest science policy news. Subscribe to our bi-weekly AIBS Public Policy Report.